Basf (ETR:BAS) Earns “Neutral” Rating from DZ Bank

Share on StockTwits

DZ Bank reaffirmed their neutral rating on shares of Basf (ETR:BAS) in a report published on Monday morning, Borsen Zeitung reports.

A number of other research firms have also weighed in on BAS. Morgan Stanley set a €67.00 ($77.91) price target on shares of Basf and gave the stock a neutral rating in a research report on Monday, July 15th. Jefferies Financial Group set a €60.00 ($69.77) target price on shares of Basf and gave the stock a neutral rating in a research report on Monday, August 19th. Barclays set a €66.00 ($76.74) target price on shares of Basf and gave the stock a neutral rating in a research report on Wednesday, July 31st. Goldman Sachs Group set a €66.00 ($76.74) target price on shares of Basf and gave the stock a neutral rating in a research report on Thursday, October 3rd. Finally, Deutsche Bank set a €74.00 ($86.05) target price on shares of Basf and gave the stock a buy rating in a research report on Monday, September 30th. One investment analyst has rated the stock with a sell rating, sixteen have given a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of €66.37 ($77.17).

BAS opened at €62.05 ($72.15) on Monday. The firm has a market cap of $56.99 billion and a P/E ratio of 6.07. Basf has a 1-year low of €55.64 ($64.70) and a 1-year high of €74.61 ($86.76). The company has a 50 day simple moving average of €61.33 and a two-hundred day simple moving average of €63.51. The company has a debt-to-equity ratio of 51.50, a current ratio of 1.69 and a quick ratio of 0.98.

Basf Company Profile

BASF SE operates as a chemical company worldwide. It operates through six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The Chemicals segment provides petrochemicals and intermediates. The Materials segment offers advanced materials and their precursors for applications and systems, such as isocyanates and polyamides, as well as inorganic basic products and specialties for plastic and plastic processing industries.

See Also: Balanced Fund

Analyst Recommendations for Basf (ETR:BAS)

Receive News & Ratings for Basf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basf and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Daiwa Securities Group Inc. Buys 11,500 Shares of Altice USA Inc
Daiwa Securities Group Inc. Buys 11,500 Shares of Altice USA Inc
Daiwa Securities Group Inc. Purchases 800 Shares of PACCAR Inc
Daiwa Securities Group Inc. Purchases 800 Shares of PACCAR Inc
Research Analysts’ Recent Ratings Updates for Barclays
Research Analysts’ Recent Ratings Updates for Barclays
-$0.14 Earnings Per Share Expected for Vascular Biogenics Ltd  This Quarter
-$0.14 Earnings Per Share Expected for Vascular Biogenics Ltd This Quarter
Eagle Asset Management Inc. Has $8.45 Million Holdings in Willdan Group, Inc.
Eagle Asset Management Inc. Has $8.45 Million Holdings in Willdan Group, Inc.
Eagle Asset Management Inc. Boosts Stock Position in WD-40
Eagle Asset Management Inc. Boosts Stock Position in WD-40


© 2006-2019 Ticker Report